VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
INAB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
INABIN8bio, Inc.
$1.39$6M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksINABQuarterly Financials

IN8bio, Inc. (INAB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

IN8bio, Inc. (INAB) quarterly income statement — complete revenue, gross profit & net income history

INAB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses5.27M4.94M3.85M5.09M5.55M6.16M7.09M8.63M8.56M7.93M7.17M7.71M7.53M7.8M7.4M7.18M6.14M5.85M3.39M3.05M
OpEx % of Revenue--------------------
Selling, General & Admin2.65M2.38M1.86M2.71M2.69M2.63M2.73M3.53M3.74M3.08M3.38M3.58M3.47M3.88M3.14M3.67M3.76M3.16M2.04M986K
SG&A % of Revenue--------------------
Research & Development2.61M2.65M2.1M2.49M2.97M3.59M3.31M5.16M4.9M4.52M3.79M4.13M4.38M3.92M4.25M3.5M2.38M2.69M1.35M2.06M
R&D % of Revenue--------------------
Other Operating Expenses0-91K-113K-107K-110K-64K1000K-60K-83K330K00-330K0000000
Operating Income-5.09M-4.94M-3.85M-5.09M-5.55M-6.16M-7.09M-8.63M-8.56M-7.93M-7.17M-7.71M-7.53M-7.8M-7.4M-7.18M-6.14M-5.85M-3.39M-3.05M
Operating Margin %--------------------
Operating Income Growth %8.29%19.77%45.61%40.97%35.18%22.3%1.16%-11.85%-13.78%-1.67%3.11%-7.47%-22.46%-33.32%-118.2%-135.38%-160.05%-153.09%--6.12%
EBITDA-5.09M-4.42M-3.33M-4.31M-4.88M-5.46M-6.4M-8M-7.93M-7.3M-6.52M-7.08M-6.93M-7.45M-7.15M-6.91M-5.91M-5.62M-3.19M-2.86M
EBITDA Margin %--------------------
EBITDA Growth %-4.28%19%47.98%46.11%38.45%25.24%1.93%-13%-14.35%1.96%8.82%-2.51%-17.28%-32.63%-124.09%-141.43%-169.02%-145.3%--0.28%
D&A (Non-Cash Add-back)0521K527K784K669K702K690K631K632K627K647K637K590K351K246K274K232K234K199K190K
EBIT0-5.03M-3.85M-5.2M-5.66M-6.22M-6.04M-8.69M-8.64M-7.93M-7.17M-7.71M-7.53M-7.8M-7.4M-7.18M-6.14M-5.85M-3.39M-3.05M
Net Interest Income091K113K107K110K64K23K60K83K00000000000
Interest Income176K91K113K107K110K64K23K60K83K00000000000
Interest Expense00000000000000000000
Other Income/Expense000000000330K0000000000
Pretax Income-5.09M-4.94M-3.85M-5.09M-5.55M-6.16M-7.09M-8.63M-8.56M-7.6M-7.17M-7.71M-7.53M-7.8M-7.4M-7.18M-6.14M-5.85M-3.39M-3.05M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-5.09M-4.94M-3.85M-5.09M-5.55M-6.16M-7.09M-8.63M-8.56M-7.6M-7.17M-7.71M-7.53M-7.8M-7.4M-7.18M-6.14M-5.85M-3.39M-3.05M
Net Margin %--------------------
Net Income Growth %8.29%19.77%45.61%40.97%35.18%18.93%1.16%-11.85%-13.78%2.56%3.11%-7.47%-22.46%-33.32%-118.2%-135.38%-160.05%-153.09%--6.12%
Net Income (Continuing)-5.09M-4.94M-3.85M-5.09M-5.55M-6.16M-7.09M-8.63M-8.56M-7.6M-7.17M-7.71M-7.53M-7.8M-7.4M-7.18M-6.14M-5.85M-3.39M-3.05M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.26-0.51-0.85-1.24-0.07-0.09-0.15-0.19-0.20-0.21-0.23-0.27-0.30-0.32-0.34-0.38-0.33-0.31-0.18-0.16
EPS Growth %-290.98%-500%-466.67%-552.63%66.75%59.52%34.78%29.63%33.33%34.38%32.35%28.95%9.09%-3.23%-88.89%-137.5%-175%-158.33%-15.79%
EPS (Basic)-0.26-0.51-0.85-1.24-0.07-0.09-0.15-0.19-0.20-0.21-0.23-0.27-0.30-0.32-0.34-0.38-0.33-0.31-0.18-0.16
Diluted Shares Outstanding19.47M4.37M4.54M4.12M83.48M56.67M47.32M45.13M43.29M35.8M31.55M28.47M24.73M24.55M21.66M18.83M18.8M18.78M18.75M18.75M
Basic Shares Outstanding19.47M4.37M4.54M4.12M83.48M56.67M47.32M45.13M43.29M35.8M31.55M28.47M24.73M24.55M21.66M18.83M18.8M18.78M18.75M18.75M
Dividend Payout Ratio--------------------